Effect of increasing duration of diabetes mellitus type 2 on glycated hemoglobin and insulin sensitivity

The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. (1995); 44: 968–983.

Stratton, I.M., Adler, A.I., Neil, H.A.et al. (2002). Association of glycemia with macrovascular and microvascular complications of type 2 diabetes, (UKPDS 35) prospective observational study. BMJ 321, 405–412.

Burm, H.F., Haney, D.N., Grabbay, K.H.et al. (1975). Further identification of the nature and the linkage of the carbohydrates in hemoglobin Alc Biochem. Biophys. Res. Comm. 67, 103–109.

Rahbar, S. (1968). An abnormal hemoglobin in red cells of diabetics. Clin. Chim. Acta. 22, 296–298.

Trivelli, L.A., Ranney, H.M. and Lai, H-T. (1971). Hemoglobin components in patients with diabetes mellitus. N. Engl. J. Med. 284, 353–357.

Arnetz, B.B., Kallner, A. and Theorell, T. (1982). The influence of aging on HbA1c. J. Gerontol. 37, 648–650.

Kilpatrick, E.S., Dominiczak, M.H. and Small, M. (1996). The effects of aging on glycation and the interpretation of glycemic control in type 2 diabetes. Q.J. Med. 89, 307–312.

Kabadi, U.M. (1998). Glycosylation of proteins. Lack of influence on aging. Diabetes Care 11, 421–432.

Defronzo, R.A., Bonadonna, R.C. and Ferrannini, E. (1992). Pathogenesis of NIDDM: A balanced overview. Diabetes Care, 15 (3), 318–368.

Mykkanen, L., Zaccaro, D.J., Hales, C.N., Festa, A. and Haffner, S.M. (1999). The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type 2 diabetes: The Insulin Resistance Atherosclerosis Study. Diabetologia 42 (9), 1060–1066.

The expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care (1997), 10, 1183–1197.

David, M. and Nathan, M.D. (2002). Initial management of glycemia in type 2 diabetes mellitus. NEJM 347 (17), 1342–1349.

Rao, G.M., Morghom, L.O., Abukhris, A.A., Mansori, S.S., Alphgih, F.A. and Ragale, L.Y. (1986). HbA1c and blood glucose levels in Libyan diabetic patients. Trop. Geogr. Med. 38 (4), 391–397.

Shera, A.S., Jawad, F., Maqsood, A., Jamal, S., Azfar, M. and Ahmed, U. (2004). Prevalence of chronic complications and associated factors in type 2 diabetes. J. Pak. Med. Assoc. 54 (2), 54–59.

Sampson, M.J., Hughes, D.A., Carrier, M.J. and Davies, I.R. (2002). Status of HbA1c during acute hyperglycemia in type 2 diabetes. Diabetes care 25, 537–541.

Rosetti, L., Giaccari, A. and Defronzo, R. (1990) Glucose toxicity. Diabetes care 13, 610–630.

Yki-Jarvinen, H. (1992). Glucose toxicity. Endocr Rev. 13, 415–431.

Mandarino, L., Baker, B., Rizza, R., Genest, J. and Gerich, J. (1984). Infusion of insulin repairs human adipocyte, glucose metabolism in vitro without decreasing adipocyte insulin receptor binding. Diabetologia 27, 358–363.

Mathews, D., Hosker, J. and Naylor, B. (1985). Insulin resistance and beta-cell functioning from fasting plasma glucose and insulin concentration in man. Diabetologia 28, 412–419.

Reaven, G. (1995). Pathophysiology of insulin resistance in human disease. Physiol. Rev. 75, 473–486.

Meneilly, G.S. and Tessier, D. (1995). Diabetes in the elderly. Diabet. Med. 12, 949–960.

Evans, J.L. and Goldfine, I.D. (2002). Glucose Status in Postmenopausal women. Endocr. Rev. 23, 599–622.

Mayumi, O., Seiji, N., Yoko, I., Eiko, Y.et al. (2003). Effects of Post-menopausal Hormone Replacement Therapy on HbA1c levels. Diabetes care 26, 1088–1092.

Clark, C.M. Jr. and Vinicor, F. (1996). Introduction: Risks of benefits of intensive management in NIDDM. The Fifth Regenstrief. Conference. Ann. Intern. Med. 124, 81–85.

Colwell, J.A. (1996). The feasibility of intensive insulin management in NIDDM: Implications of the Veterans Affairs Cooperative Study on Glycemic Control and complications in NIDDM. Ann. Intern. Med. 124, 131–135.

Kitabchi, A.E. and Bryer Ash, M. (1997). NIDDM: New aspects of management. Hosp. Pract. 32, 135–164.

Gloria-Botthini, F., Antonacci, E., Bottini, N., Ogana, A., Borgiani, P., De Santis, G. and Lucarini, N. (2000). Rh blood groups and diabetic disorders: Is there an effect on glycosylated hemoglobin level? Hum. Biol. 72 (2), 287–294.